RVMDW: Revolution Medicines Inc. Warrant Stocks News on November 22, 2024

$Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer$

RVMDW

GlobeNewswire

4 months ago

Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory KRAS-Mutated Non-Small Cell Lung Cancer

Revolution Medicines (RVMD) Moves 11.0% Higher: Will This Strength Last?

RVMDW

Zacks

4 months ago

Revolution Medicines (RVMD) Moves 11.0% Higher: Will This Strength Last?

Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024

RVMDW

GlobeNewswire

4 months ago

Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024

RVMDW

MT Newswires

4 months ago

Jefferies Initiates Revolution Medicines at Buy With $63 Price Target

Insider Sale: COO Margaret Horn Sells Shares of Revolution Medicines Inc (RVMD)

RVMDW

GuruFocus.com

5 months ago

Insider Sale: COO Margaret Horn Sells Shares of Revolution Medicines Inc (RVMD)

RVMDW

MT Newswires

5 months ago

Revolution Medicines Insider Sold Shares Worth $446,770, According to a Recent SEC Filing

Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable

RVMDW

Simply Wall St.

5 months ago

Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable

Edge Total Intelligence Inc. Updates Status of MCTO

RVMDW

Newsfile

5 months ago

Edge Total Intelligence Inc. Updates Status of MCTO

Fortegra Granted License to Operate in Belgium and European Union

RVMDW

PR Newswire

5 months ago

Fortegra Granted License to Operate in Belgium and European Union

Jamaica Villas Offers "Free Driver" Promotion As Part Of Its Redesigned Website Launch

RVMDW

PR Newswire

5 months ago

Jamaica Villas Offers "Free Driver" Promotion As Part Of Its Redesigned Website Launch

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

RVMDW

CNW Group

5 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

RVMDW

GlobeNewswire

5 months ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

RVMDW

GlobeNewswire

5 months ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

RVMDW

GlobeNewswire

5 months ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

RVMDW

GlobeNewswire

5 months ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

RVMDW

MT Newswires

6 months ago

Revolution Medicines Insider Sold Shares Worth $299,942, According to a Recent SEC Filing

Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

RVMDW

GlobeNewswire

6 months ago

Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...

RVMDW

GuruFocus.com

6 months ago

Revolution Medicines Reports Q1 2024 Financial Results: Challenges and Strategic Advances in ...

Revolution Medicines First Quarter 2024 Earnings: US$0.70 loss per share (vs US$0.72 loss in 1Q 2023)

RVMDW

Simply Wall St.

6 months ago

Revolution Medicines First Quarter 2024 Earnings: US$0.70 loss per share (vs US$0.72 loss in 1Q 2023)

Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2024 Earnings Call Transcript

RVMDW

Insider Monkey

6 months ago

Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2024 Earnings Call Transcript

RVMDW

MT Newswires

6 months ago

Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating

RVMDW

GuruFocus.com

6 months ago

Revolution Medicines Inc (RVMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...

RVMDW

MT Newswires

6 months ago

Revolution Medicines Q1 Net Loss Narrows

Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

RVMDW

GlobeNewswire

6 months ago

Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress

Insider Sale: CFO Jack Anders Sells 10,000 Shares of Revolution Medicines Inc (RVMD)

RVMDW

GuruFocus.com

7 months ago

Insider Sale: CFO Jack Anders Sells 10,000 Shares of Revolution Medicines Inc (RVMD)

Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024

RVMDW

GlobeNewswire

7 months ago

Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024

Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

RVMDW

GlobeNewswire

7 months ago

Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

RVMDW

GlobeNewswire

7 months ago

Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

RVMDW

GlobeNewswire

8 months ago

Revolution Medicines to Participate in Upcoming Investor Conferences

Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024

RVMDW

GlobeNewswire

8 months ago

Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024

Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript

RVMDW

Insider Monkey

9 months ago

Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript

Revolution Medicines Full Year 2023 Earnings: Misses Expectations

RVMDW

Simply Wall St.

9 months ago

Revolution Medicines Full Year 2023 Earnings: Misses Expectations

RVMDW

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Revolution Medicines Inc Earnings Call

Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates

RVMDW

Zacks

9 months ago

Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates

Revolution Medicines Inc (RVMD) Reports Earnings: R&D Investments Surge Amidst Clinical Progress

RVMDW

GuruFocus.com

9 months ago

Revolution Medicines Inc (RVMD) Reports Earnings: R&D Investments Surge Amidst Clinical Progress

Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

RVMDW

GlobeNewswire

9 months ago

Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024

RVMDW

GlobeNewswire

9 months ago

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024

Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout

RVMDW

Zacks

10 months ago

Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout

RVMDW

GlobeNewswire

10 months ago

Revolution Medicines to Participate in Upcoming Investor Conferences

Chapel Hart Kicks Off Ford Truck Month with "This Girl Likes Fords"

RVMDW

Business Wire

10 months ago

Chapel Hart Kicks Off Ford Truck Month with "This Girl Likes Fords"

Are You Looking for a High-Growth Dividend Stock?

RVMDW

Zacks

10 months ago

Are You Looking for a High-Growth Dividend Stock?

E2IP strengthens its Board of Directors for accelerated global scalability. Accomplished CEO and Fortune 500 Executive, Michael J. Loparco, joins E2IP Board of Directors

RVMDW

PR Newswire

10 months ago

E2IP strengthens its Board of Directors for accelerated global scalability. Accomplished CEO and Fortune 500 Executive, Michael J. Loparco, joins E2IP Board of Directors

HS2 bosses in talks to scrap first-class seats to maintain passenger capacity

RVMDW

The Telegraph

10 months ago

HS2 bosses in talks to scrap first-class seats to maintain passenger capacity

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

RVMDW

Motley Fool

10 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

RVMDW

Associated Press Finance

10 months ago

First Merchants: Q4 Earnings Snapshot

First Merchants Corporation Announces Fourth Quarter 2023 Earnings Per Share

RVMDW

GlobeNewswire

10 months ago

First Merchants Corporation Announces Fourth Quarter 2023 Earnings Per Share

Meta Materials Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

RVMDW

ACCESSWIRE

10 months ago

Meta Materials Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

Wall Street Analysts See a 27.5% Upside in Revolution Medicines, Inc. (RVMD): Can the Stock Really Move This High?

RVMDW

Zacks

10 months ago

Wall Street Analysts See a 27.5% Upside in Revolution Medicines, Inc. (RVMD): Can the Stock Really Move This High?

RVMDW

GlobeNewswire

10 months ago

WinVest Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date

Senior Vice President David Knutson Sells 20,000 Shares of NextNav Inc

RVMDW

GuruFocus.com

10 months ago

Senior Vice President David Knutson Sells 20,000 Shares of NextNav Inc

With 68% ownership, Spring Valley Acquisition Corp. II (NASDAQ:SVII) boasts of strong institutional backing

RVMDW

Simply Wall St.

10 months ago

With 68% ownership, Spring Valley Acquisition Corp. II (NASDAQ:SVII) boasts of strong institutional backing

Edible Garden Available at Uncle Giuseppe’s Marketplace; Expands Company’s Distribution Network

RVMDW

GlobeNewswire

10 months ago

Edible Garden Available at Uncle Giuseppe’s Marketplace; Expands Company’s Distribution Network

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

RVMDW

NewMediaWire

10 months ago

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

Carnival upgraded, PayPal downgraded: Wall Street's top analyst calls

RVMDW

The Fly

a year ago

Carnival upgraded, PayPal downgraded: Wall Street's top analyst calls

Edible Garden Launches PulpFlavors.com E-Commerce Site

RVMDW

GlobeNewswire

a year ago

Edible Garden Launches PulpFlavors.com E-Commerce Site

ZyVersa Therapeutics Announces Equity Research Coverage Initiated by Noble Capital Markets

RVMDW

GlobeNewswire

a year ago

ZyVersa Therapeutics Announces Equity Research Coverage Initiated by Noble Capital Markets

Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference

RVMDW

GlobeNewswire

a year ago

Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference

ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Providing Outlook for 2024

RVMDW

GlobeNewswire

a year ago

ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Providing Outlook for 2024

RVMDW

GlobeNewswire

a year ago

Aclarion Announces Reverse Stock Split

Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

RVMDW

PR Newswire

a year ago

Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds

Hudson Acquisition I Corp. Regains Compliance with Nasdaq Listing Rule 5250(c)(1)

RVMDW

GlobeNewswire

a year ago

Hudson Acquisition I Corp. Regains Compliance with Nasdaq Listing Rule 5250(c)(1)

SOBRsafe Launches Expanded E-Commerce Website, Debuts Teen Driver Safety Video

RVMDW

ACCESSWIRE

a year ago

Latest Revolution Medicines Inc. Warrant (RVMDW) News on November 22, 2024

Share on Social Networks: